Shaw, J.; Elsawy, M.; Nielsen, R.; Harrigan, A.M.; DiCostanzo, T.T.; Minard, L.V.
Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada. Curr. Oncol. 2025, 32, 2.
https://doi.org/10.3390/curroncol32010002
AMA Style
Shaw J, Elsawy M, Nielsen R, Harrigan AM, DiCostanzo TT, Minard LV.
Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada. Current Oncology. 2025; 32(1):2.
https://doi.org/10.3390/curroncol32010002
Chicago/Turabian Style
Shaw, Jenna, Mahmoud Elsawy, Rachel Nielsen, Amye Michelle Harrigan, Tara T. DiCostanzo, and Laura V. Minard.
2025. "Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada" Current Oncology 32, no. 1: 2.
https://doi.org/10.3390/curroncol32010002
APA Style
Shaw, J., Elsawy, M., Nielsen, R., Harrigan, A. M., DiCostanzo, T. T., & Minard, L. V.
(2025). Real-World Characterization of Toxicities and Medication Management in Recipients of CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma in Nova Scotia, Canada. Current Oncology, 32(1), 2.
https://doi.org/10.3390/curroncol32010002
